An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

In this section: Approved Blood Products

Advate

STN: BL 125063
Proper Name: Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method
Tradename: Advate
Manufacturer: Baxter Healthcare Corp, License #0140

Indication:

An Antihemophilic Factor (Recombinant) indicated for:
- Control and prevention of bleeding episodes in adults and children (0-16 years) with Hemophilia A.
- Perioperative management in adults and children (0-16 years) with Hemophilia A.
- Routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children (0-16 years) with Hemophilia A.
Advate is not indicated for the treatment of von Willebrand disease.

Product Information

Package Insert - Advate

Supporting Documents

Supporting Documents older than three years - Advate

Related Information

FDA Online Label Repository
Search this database for drug labeling and other information. The content has not been altered or verified by the FDA and may not be the labeling on currently distributed products or identical to the labeling that is approved.

Top